Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Chinook Therapeutics Inc (KDNY)

Chinook Therapeutics Inc (KDNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, NETI, TALS, QUOT PR Newswire - Tue Jul 25, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

TALS : 2.72 (-0.73%)
KDNY : 40.39 (+0.22%)
NETI : 11.33 (+0.09%)
QUOT : 3.99 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRDS, KDNY, AEL PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

PRDS : 2.16 (unch)
KDNY : 40.39 (+0.22%)
AEL : 56.47 (+0.55%)
Moore Kuehn Encourages CWBR, KDNY, GHL, and DM Investors to Contact Law Firm PR Newswire - Mon Jul 17, 2023

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

KDNY : 40.39 (+0.22%)
DM : 4.96 (+1.02%)
GHL : 14.99 (-0.13%)
CWBR : 0.4100 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY PR Newswire - Wed Jul 12, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX PR Newswire - Mon Jul 10, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMNM : 20.11 (+0.10%)
KDNY : 40.39 (+0.22%)
WMC : 9.18 (+4.44%)
AJX : 3.02 (-0.66%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates KDNY, FRG, ARNC PR Newswire - Mon Jul 3, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
ARNC : 29.99 (+0.03%)
FRG : 29.88 (+0.10%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, KDNY, PTEN, FRG PR Newswire - Tue Jun 27, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
FOCS : 52.99 (-0.02%)
PTEN : 6.44 (-0.62%)
FRG : 29.88 (+0.10%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Chinook Therapeutics, Inc. - KDNY PR Newswire - Fri Jun 23, 2023

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Chinook Therapeutics, Inc. ("Chinook" or the "Company") (NASDAQ: KDNY). Such...

KDNY : 40.39 (+0.22%)
Why Shares of Vera Therapeutics Jumped Tuesday Motley Fool - Tue Jun 20, 2023

The company announced early phase 2 trials information regarding its lead therapy.

VERA : 45.44 (+6.64%)
KDNY : 40.39 (+0.22%)
NVS : 132.93 (+0.38%)

Barchart Exclusives

Cathie Wood Is Still Buying Meta Platforms Stock. Should You? Barchart - 41 seconds ago
ARK added shares in META worth $21.4 million across three ETFs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot